Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin as adjunctive therapy for schizophrenia
NL-OMON22886Active, not recruiting
- Start
- Jan 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of aspirin in schizophrenia, schizoaffective disorder and schizophreniform disorder (2 arms). Primary endpoint: Change in total PANSS score at 3 months. Started Jan 2004; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NL-OMON22886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22886.